FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Director - Benjamin Shneider, MD
Baylor College of Medicine
Principal Investigator - Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Director - John Magee, MD
University of Michigan Medical Center, Ann Arbor
Principal Investigator - Lisa Henn, PhD
Arbor Research Collaborative of Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- University of California at San Francisco (ucsf)
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S Healthcare of Atlanta (emory University)
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Cincinnati Children'S Memorial Hospital
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Texas Children'S Hospital (baylor College of Medicine)
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Nov 2016
- Primary completion
- 22 Dec 2022
- Completion
- 22 Dec 2022
- Last update posted
- 28 Aug 2024
- Registered enrollment
- 552
- Registry id
- NCT02922751
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.